Article By:
Sweta Killa
Monday, October 17, 2016 2:29 PM EDT
Biotech stocks had a tumultuous ride in the first half of 2016. Though the sector bounced back in July and recovered half of the losses, the rally fizzled again in late September due to worries over the upcoming election.